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DObjectives: To quantify right ventricular output power and efficiency and correlate these to ventricular function
in patients with repaired tetralogy of Fallot. This might aid in determining the optimal timing for pulmonary
valve replacement.
Methods: We reviewed the cardiac catheterization and magnetic resonance imaging data of 13 patients with
tetralogy of Fallot (age, 22  17 years). Using pressure and flow measurements in the main pulmonary artery,
cardiac output and regurgitation fraction, right ventricular (RV) power output, loss, and efficiency were calcu-
lated. The RV function was evaluated using cardiac magnetic resonance imaging.
Results: The RV systolic power was 1.08  0.62 W, with 20.3%  8.6% power loss owing to 41%  14%
pulmonary regurgitation (efficiency, 79.7%  8.6%; 0.84  0.73 W), resulting in a net cardiac output of
4.24  1.82 L/min. Power loss correlated significantly with the indexed RVend-diastolic and end-systolic vol-
ume (R ¼ 0.78, P ¼ .002 and R ¼ 0.69, P ¼ .009, respectively). The normalized RV power output had
a significant negative correlation with RV end-diastolic and end-systolic volumes (both R ¼0.87, P ¼ .002
and R ¼0.68, P ¼ .023, respectively). A rapid decrease occurred in the RV power capacity with an increasing
RV volume, with the curve flattening out at an indexed RV end-diastolic and end-systolic volume threshold of
139 mL/m2 and 75 mL/m2, respectively.
Conclusions: Significant power loss is present in patients with repaired tetralogy of Fallot and pulmonary
regurgitation. A rapid decrease in efficiency occurs with increasing RV volume, suggesting that pulmonary
valve replacement should be done before the critical value of 139 mL/m2 and 75 mL/m2 for the RV
end-diastolic and end-systolic volume, respectively, to preserve RV function. (J Thorac Cardiovasc Surg
2012;143:1279-85)The repair of tetralogy of Fallot (TOF),1 which has pulmo-
nary stenosis present, consists of placing a transannular
patch across the right ventricular (RV) outflow tract to re-
lieve the obstruction that results in pulmonary regurgitation
(PR) and imposes a volume load on the RV.2,3 This RV
volume load affects the RV function at rest as well as at
exercise, and has been correlated with the degree of PR.4-6
Once the PR is abolished by placement of a competent
pulmonary valve, exercise tolerance improves.7,8
We hypothesized that parameters such as RV volume, RV
mass, and PR, which have been previously characterized in
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The Journal of Thoracic and Carperformance—RV power output. Because the right ventri-
cle must pump the regurgitant as well as the net stroke vol-
ume, we further hypothesized that this results in wasted
power by the heart. The increased power needed might be
a significant contributor to the etiology of ventricular dys-
function,5,6 exercise intolerance,4,5 and dysrhythmias that
these patients experience. The quantification of this
‘‘wasted’’ power and its association with other parameters
of ventricular performance might be the key toward
understanding the limitations in patients with TOF and
toward improving the medical, surgical, or catheter (eg,
pulmonary valve replacement) management.
Cardiac magnetic resonance (CMR) cine imaging6 and
phase contrast-CMR (PC-CMR)9 can accurately quantify
the ventricular volume, cardiac index, and PR. Combined
with measures of right-sided pressures by cardiac cathe-
terization, power output, and power loss (PL) associated
with PR and their association with standard measures
of ventricular performance can be quantified. The hypoth-
esis of the present study was twofold: significant PL is
present in patients with TOF with PR; and that the PL
has a significant effect on global ventricular function.
We speculated that PL might be the global parameter
that can explain decreasing RV function, could be the
sentinel of deteriorating cardiorespiratory performancediovascular Surgery c Volume 143, Number 6 1279
Abbreviations and Acronyms
CMR ¼ cardiac magnetic resonance
TOF ¼ tetralogy of Fallot
PC-CMR ¼ phase contrast-CMR
PL ¼ power loss
RV ¼ right ventricular
RVEDVI ¼ right ventricular end-diastolic
volume indexed to standard
clinical form
RVEDVNormalized ¼ ‘‘normalized’’ right
ventricular end-diastolic
volume
RVESVI ¼ right ventricular end-systolic
volume indexed to standard
clinical form
RVESVNormalized ¼ ‘‘normalized’’ right
ventricular end-systolic
volume
RVOT ¼ right ventricular outflow tract
PR ¼ pulmonary regurgitation
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replacement.PATIENTS AND METHODS
Patients
Thirteen consecutive patients with repaired TOF and PR who under-
went CMR and catheterization were enrolled in the present retrospective
study, which was approved by the institutional review board. These pa-
tients underwent catheterization for possible interventional procedures
(eg, stent placement, electrophysiologic testing). The patients with
a peak velocity across the RVoutflow tract (RVOT) of>3 m/s by echocar-
diography were excluded. The average interval between CMR and cathe-
terization was 2  3 months. All patients, except for 1, underwent
transannular patch repair of the RVOT; that patient underwent conduit
placement. None underwent monocusp RVOT reconstruction or another
valved type of intervention. Eight patients without right-sided lesions
and normal right ventricles (5 with coarctation and 3 with aortic valve dis-
ease) were included as controls.
CMR Imaging Protocol
A standard electrocardiographic-gated CMR examination was per-
formed on a 1.5-Tesla Siemens Avanto magnetic resonance system
(Siemens Medical Solutions, Malvern, Pa). This consisted of static,
steady-state, free precession for anatomy, cine CMR imaging for ventricu-
lar performance parameters (volumes), delayed enhancement to discern
myocardial scarring, and PC-CMR for evaluation of the pulmonary flow.
From PC-CMR imaging, the cardiac index was obtained. From cine
CMR imaging, the ventricular function parameters such as RV end-
diastolic volume, ejection fraction, and cardiac index were evaluated. De-
layed enhancement imaging was used to determine myocardial scarring.
Cardiac Catheterization
Standard catheterization for TOFwas performed. The oxygen saturation
and pressure were obtained from both right- and left-sided structures1280 The Journal of Thoracic and Cardiovascular Suraccording to the routine protocol. Catheterizations were performed for di-
agnostic reasons and intervention (stent placement) under sedation.
Other Clinical Data
Routine echocardiographic data were collected to determine the grade
of tricuspid insufficiency and the assessment of the RVOT. Electrocardio-
grams were obtained to assess the QRS duration.
Data Processing
Ventricular function. The ARGUS software (ARUGUS Software,
Houston, Tex), resident on Siemens workstations, was used to evaluate
ventricular function. The endocardial borders were traced (semiautomati-
cally) by an expert observer. The segmented CMR slices were integrated
along the long axis using Simpson’s rule to extract the total ventricular
volumes.
Flow quantification. An in-house program using Matlab (Math-
Works, Natick, Mass), described previously,10 was used to process the
PC-CMR images. The regurgitant fraction is the reverse flow divided by
the forward flow multiplied by 100.
Evaluation of power output. Flow waveforms from PC-CMR
and the systolic and diastolic pressures from catheterization were used to
quantify the power output according to following equation:
Power ¼ 0:5$r$v2meanþPmean

$Qmean;
where r is the blood density (a constant value of 1060 kg/m3), v is the mean
systolic velocity calculated in the systolic phase from PC-CMR (Qmean/
Areamean), Pmean is the mean static systolic pressure measured in the
main pulmonary artery during cardiac catheterization, and Qmean is the
mean flow rate in the systolic phase (forward flow, Figure 1) calculated
from PC-CMR. The power output thus calculated is the mean power gen-
erated by the right ventricle in systole. This method has been used previ-
ously to evaluate the ventricular power output in single ventricle
physiology.10
Evaluation of power loss. Similar to the power output, the PL due
to PR was also evaluated using the previous equation. The mean diastolic
pressure in the main pulmonary artery measured from catheterization was
used as the Pmean, the mean flow in the diastolic phase (backward flow,
Figure 1) was used as the Qmean, and the mean backward velocity was
used as the vmean, all derived from PC-CMR. The net efficiency was as
follows:
Efficiencyð%Þ ¼ 100$PowerTotalPowerLoss
PowerTotal
Parameter Normalization
Proper normalization of the parameters to account for patient-to-patient
variability is necessary. The normalizing/indexing power using cardiac out-
put or body surface area (BSA) assumes a linear relationship that might not
be true because power is not linearly related to cardiac output or BSA. Dasi
and colleagues11 have recently shown that r
Q3
BSA2
(where Q is the mean
flow rate or cardiac output, and r is the blood density) has the same dimen-
sion as power (Watts or kg-m2/s3), and provides the appropriate normaliz-
ing parameter for power output, which transforms it to a dimensionless
parameter (ie, dividing power by this parameter cancels out the dimensions,
making the quotient dimensionless). Similarly, a dimensionless form of
ventricular volumes was obtained by normalizing to BSA1.5, instead of
the BSA alone. This is because the unit of measure for BSA1.5 is meters
cubed, the same as for the ventricular volume. The dimensionless form
of the ventricular volume is referred to as the ‘‘normalized’’ volume (RV
end-diastolic volume [RVEDVNormalized] and RV end-systolic volume).
The present study also indexed the ventricular volumes to their standardgery c June 2012
FIGURE 1. A,Typicalmain pulmonary artery (MPA)flowwaveform in patientswith tetralogyof Fallot (TOF)with pulmonary regurgitation (PR) (top curve).
Thewaveform is divided into forward and backward phases to evaluate the total right ventricular (RV) power generated and power loss (PL) due to pulmonary
regurgitation (PR). B, The images represent how theRV function andflowwere obtained.Left, A 4-chamber view and short-axis views (rectangle on 4-chamber
view) at end diastole and end systole (from left to right). C, Velocity map plane was obtained in the MPA (top) and an example of a velocity map (bottom).
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TABLE 1. Baseline characteristics
Parameter Value
Age (y) 21.9  16.9
Body surface area (m2) 1.34  0.6
RV end-diastolic volume index (mL/m2) 142  48
RV end-systolic volume index (mL/m2) 66  37
RV ejection fraction (%) 56  11
RF (%) 40.5  13.8
LV end-diastolic volume index (mL/m2) 72  9
LV end-systolic volume index (mL/m2) 26  5
LV ejection fraction (%) 63  5
Systemic flow (Qs) (L/min)
(CMR/catheterization)
4.68  2.9/4.28  3.3
Qp (L/min) 4.24  1.8
Systemic vascular resistance (Wood units) 26.2  9.7
Pulmonary vascular resistance (Wood units) 2.54  0.94
RV end-diastolic pressure (mm Hg) 4.3  3.6
RV peak-systolic pressure (mm Hg) 49.3  20.3
RV mean systolic pressure (mm Hg) 10.77  6.1
LV end-diastolic pressure (mm Hg) 6.7  4.8
LV peak-systolic pressure (mm Hg) 102.5  22.0
LV mean systolic pressure (mm Hg) 10.62  5.30
Systolic pulmonary artery pressure (mm Hg) 36.5  11.3
Diastolic pulmonary artery pressure (mmHg) 9.4  4.5
Systolic systemic blood pressure (mm Hg) 102.6  18.4
Diastolic systemic blood pressure (mm Hg) 62.8  11.9
QRS duration (ms) 137  33
Tricuspid regurgitation
None 1
Trivial 6
Mild 6
RV power output (W) 1.08  0.62
Power loss (W) 0.24  0.18
Net efficiency (%) 79.75  8.6
RV, Right ventricular; RF, regurgitant fraction; LV, left ventricular; CMR, cardiac
magnetic resonance.
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RVESVI, respectively. The percentage of PL, percentage of ejection frac-
tion, and percentage of power efficiency are dimensionless and do not re-
quire any additional normalization.
Statistical Analysis
All values are presented as the mean  standard deviation. Descriptive
statistics were used for general characteristics of the population. The rela-
tionships between the power output and ventricular volumes were estab-
lished using their normalized dimensionless forms. PL, hydraulic
efficiency, PR, and QRS duration were correlated with the clinical indexes
of RVEDVI and RVESVI, respectively. Statistical significance was set at
P<.05. Correlations between different parameters were evaluated using
Microsoft Excel (Microsoft, Redmond, Wash) and Systat (Cranes Soft-
ware, Chicago, Ill). The Pearson coefficient of correlation was used to de-
scribe the nature of the parametric relationship.
RESULTS
Baseline Characteristics and Standard Measures of
Hemodynamics and Function
The baseline characteristics and standard measures of
hemodynamics and ventricular performance are listed in
Table 1. The right ventricle was dilated with a normal RV
ejection fraction, and the LV size, ejection fraction, and car-
diac output were normal. The QRS duration was prolonged
(137  33 ms) and the mean PR was 41%  14%. The
mean gradient across the RVOT was 12  21 mm Hg.
Tricuspid insufficiency was trivial in 6 of 13 patients and
mild in 6 patients. No significant aortic or mitral regurgita-
tion was present. No myocardial scarring was noted in any
of the patients; the RVOT patch demonstrated delayed
enhancement in all patients. The control patient age
was 12  6.7 years, with a body surface area of 1.37 
0.64 m2 and 0.21  0.26 years from catheterization to
CMR; none had PR.
Power Evaluation
The total RV power output was 1.08  0.62 W. PR re-
sulted in a PL of 0.24  0.18 W, with a net RV power gen-
eration of 0.84  0.48 W. This yielded an RV efficiency of
79.7%  8.6%. The total RV power output of the control
patients was 0.8  0.6 W, which appeared smaller than
the total RV power output of the patients with TOF,
although the difference was not statistically significant
(P ¼ .32). It was similar to the net RV power generation
of the patients with TOF (P ¼ .87). Figures 2 and 3
demonstrate the effect of PL on clinical indexes of
RVEDVI and RVESVI, respectively. Significant positive
correlations (R ¼ 0.78 and R ¼ 0.69) were noted between
PL and RVEDVI and RVESVI, respectively (Figure 2).
The RV power efficiency, which takes into account the PL
indexed to the total power output, was plotted against the
RV volumes in Figure 3. A significant inverse relationship
was noted between the efficiency and ventricular volumes
(R ¼ 0.78 and R ¼ 0.69 for RVEDVI and RVESVI,
respectively).1282 The Journal of Thoracic and Cardiovascular SurFigure 4 shows the relationship between the normalized
RV total power output and the normalized RV volumes. A
strong significant negative correlation was found between
the normalized RV output power and RVEDVNormalized.
The RV power capacity decreased drastically as the
RVEDVNormalized increased from 50 and 120 (120 is the in-
flection point at which the slope of the curve increases
from<1 to>1 and at which the second derivative of
this curve becomes 0). After 120, the curve flattens out, sug-
gesting a possible critical state, after which the RV’s ability
to pump with adequate power diminishes. Because the
mean BSA of the study population was 1.34  0.6 m2,
the RVEDVI can be estimated to be 139 mL/m2 (120 mL/
m3 3 1.340.5 m). Similarly, the RV power capacity de-
creased rapidly as the RVESVI increased, with an inflection
point at a RVESVNormalized of 65 (corresponding to a clinical
RVESVI of 75 mL/m2).
Themean LV power was 1.82 0.76W.Mitral and aortic
valve regurgitation was absent or trivial in all patients;gery c June 2012
FIGURE 2. Relationship of right ventricular (RV) power loss (PL) with
right ventricular end-diastolic volume index (RVEDVI) and right ventricu-
lar end-systolic volume index (RVESVI).
FIGURE 3. Relationship between total right ventricular (RV) power effi-
ciency and right ventricular end-diastolic and end-systolic volume indexes
(RVEDVI and RVESVI, respectively).
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the left side was minimal).
Correlations of RV Volumes and Power With Other
Measures
PR correlated well with both RVEDVI (R ¼ 0.79) and
RVESVI (R ¼ 0.72). The QRS duration did not correlate
with RVEDVI (P ¼ .806) or RVESVI (P ¼ .482). A rela-
tionship between the RVOT gradient and RV power output
(P¼ .35) and PL (P¼ .24) was not present. Age also did not
correlate with RV power output (P ¼ .27); however, it did
correlate with PL (R ¼ 0.57, P ¼ .04).
DISCUSSION
Power is simply energy per unit of time, and it would
make sense that a heart that is required to pump a larger vol-
ume of blood must also expendmore energy per unit of time
to do so. The present study demonstrated that PL (average
PL of 0.24 W in patients with TOF) can be assessed using
a combination of CMR and catheterization. The mean value
of the total RV power output of the patients with TOF was
1.08 W compared with 0.8 W in the control group. As ex-
pected, PL positively correlated with increasing RVEDVI,The Journal of Thoracic and CarRVESVI, and age. In addition, as the RVEDVI increased,
a linear decrease occurred in RVefficiency, but a precipitous
decrease occurred in the RV power output in an exponential
fashion. The inflection point of the curve of RV power out-
put versus RVEDVNormalized was 120mL/m
3, corresponding
to an estimated RVEDVI of 139 mL/m2.
Multiple studies have used routine parameters of ventric-
ular function or flow to assess the postoperative TOF patient
with PR. Nearly all have shown that depressed biventricular
function is present at rest and during exercise using a num-
ber of different techniques such as CMR and radionuclide
angiography.5,12 PR was correlated with a depressed LV
ejection fraction (r ¼ 0.68) and exercise tolerance
(r ¼ 0.50) by Niezen and colleagues.12 Wessel and
Paul13 performed a review of 22 exercise studies from
1990 onward and found that 14 had found a significant re-
lationship of the degree of PR with abnormal RV function
and decreased exercise capacity.
There have also been attempts to correlate ventricular
performance and clinical status. Knauth and colleagues,14
in a follow-up period of just longer than 4 years, found
that a greater RVEDVI (>7 standard deviations) and a lower
RVejection fraction (<45%) correlated with an increasingdiovascular Surgery c Volume 143, Number 6 1283
FIGURE 4. Relationship between normalized right ventricular (RV)
power output and normalized RVend-diastolic and end-systolic volume in-
dexes (RVEDVNormalized and RVESVNormalized, respectively). Two sets of
points (108.8 and 94.1 and 108.3 and 94.0) are right on top of each other
and seem to appear as a single point.
Congenital Heart Disease Fogel et al
C
H
Dprobability of adverse events. An increasing New York
Heart Association class has been found to be associated
with lower LV ejection fraction (odds ratio, 3.88 for
a 10% decrease; P ¼ .002) and lower RV ejection fraction
(odds ratio, 2.41 for a 10% decrease; P ¼ .01).6 The regur-
gitant fraction, RVEDVI, and all the mentioned parameters
result from the RV volume load due to the PR. These param-
eters are surrogates for the effect of the RV volume load on
RV energetics, which is a more integrated assessment of
function, drills down to ventricular performance on
a more basic level and has been correlated with myocardial
oxygen consumption.15 It could serve as a useful tool in pre-
dicting the clinical outcome and be a sentinel for deteriorat-
ing cardiorespiratory status.
Although this is the first study to demonstrate PLs in pa-
tients with TOF and its association with RV volumes, this is
not the first study of power output or PL in congenital heart
disease. Sundareswaran and collagues10 demonstrated that
patients with hypoplastic left heart syndrome had a much
lower power capacity than patients with other forms of1284 The Journal of Thoracic and Cardiovascular Sursingle-ventricle morphology. In patients with Fontan circu-
lation, Pekkan and colleagues16 demonstrated that a 7% de-
crease in energy losses corresponded with an 11% increase
in cardiac output. Our laboratory has also shown a nonlinear,
almost exponential increase in energy losses in the systemic
venous pathway with increasing cardiac output.17
The findings of the present study, however, have implica-
tions beyond the realm of TOF and can be applied to other
forms of heart disease. For example, repair of truncus arte-
riosus results in PR. Furthermore, the concept of PL in re-
gurgitant lesions can be applied to adult valvular disease
such as aortic or mitral insufficiency. PL could be a unifying
concept and could possibly find utility as a predictor of out-
comes; our findings might be the groundwork to investigate
this concept in more detail.
PLs in the patient with TOF could have a clinical effect
with regard to the timing of pulmonary valve replacement.
RV volumes have been used as the key parameter in the
past. Therrien and collagues18 studied 17 patients with
TOF using CMR before and after pulmonary valve replace-
ment and found that the RVEDVI and RVESVI decreased
34% and 37%, respectively. Importantly, no patient
achieved a normal RVEDVI and RVESVI after pulmonary
valve competency if their RVEDVI before surgery was
>170 mL/m2 and their RVESVI was>85 mL/m2. Valsan-
giacomo Buechel and colleagues19 performed a prospective
study with CMR in patients with TOF of approximately 14
years with pulmonary valve replacement at an RVEDVI of
greater than 150 mL/m2. They found a significant decrease
in the RV volumes and mass after valve replacement and
significant remodeling 6 months after surgery, concluding
that an RVEDVI of 150 mL/m2 was a good clinical cutoff
to undergo pulmonary valve repair. These studies corrobo-
rate our findings of using an RVEDVI of 139 mL/m2 for
pulmonary valve replacement, which is close to the cutoff
from the study by Valsangiacomo Buechel and col-
leagues.19 After this point, a greater than 1 unit of volume
change must occur in the reverse direction along the curve
shown in Figure 4 to elicit a 1-unit change in power capac-
ity. Hence, if valve replacement is performed before the
cutoff, a greater improvement in ventricular power capacity
can be achieved with ventricular remodeling. RV volumes
greater than these values are operating on the flat part of the
RV power output–RVEDVI curve, where the right ventricle
has less power output and its energetics are least favorable.
The importance of the timing of pulmonary valve replace-
ment in patients with TOF should not be underestimated.
Studies in the past decade have shown that once the right
ventricle becomes too dilated, functional recovery is
lacking.20,21
Our study is complementary to the recent report by Fri-
giola and colleagues,22 who had an aggressive pulmonary
valve replacement strategy by operating on patients with
an average RVEDVI of 142  43 mL/m2, again very closegery c June 2012
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pulmonary valve early led to RVEDVI normalization, im-
provement in biventricular function, and much improved
submaximal exercise capacity. It could be that because
this group had a much lower RVEDVI threshold to operate,
they were intervening at the steep part of the RV power out-
put curve delineated in our study, preserving RV function
and exercise capacity and facilitating improvement in RV
power capacity.
Study Limitations
This was a retrospective study with all the inherent biases
accompanying this type of investigation. We also studied
a small group of patients. A prospective study is needed
to determine whether an RVEDVI of 139 mL/m2 and an
RVESVI of 75 mL/m2 should be used as the cutoff values
to replace the pulmonary valve. CMR and cardiac catheter-
ization occurred approximately 2 months apart and were not
simultaneous with each other. No change in clinical status
was noted between these 2 examinations, and it is unlikely
that the interval in between these studies significantly af-
fected our results. In addition, the light, conscious sedation
used for catheterizations (ie, diazepam, meperidine, mida-
zolam, and fentanyl in some combination) in the doses
given generally have little effect on systemic and pulmo-
nary vascular resistance. The catheterization team would
not want to obtain data that were not reflective of the pa-
tient’s true physiology. Therefore, we believe that this did
also not significantly affect the results.
CONCLUSIONS
Patients with TOF after repair with PR experience PLs
due to the regurgitant volume of just more than 20% on av-
erage, despite a regurgitant fraction of 41%. The power out-
put of the right ventricle decreases in an exponential fashion
as the RV volume increases, with the curve flattening above
an RVEDVI of 139 mL/m2 and an RVESVI of 75 mL/m2.
The PL increases and RV power efficiency decreases with
an increasing RV volume. This has implications for the tim-
ing of pulmonary valve replacement and could contribute to
the decreased exercise performance in these patients. A pro-
spective study is warranted.
We would like to thank Dr Alvin Chin for his assistance in data
interpretation.
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